Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 13Insulin Resistance 3Hyperandrogenism 3Metabolic Syndrome 2Solid Tumors 1Primary Dysautonomias 1Overweight 1Observational Study 1Motor Activity 1Menstruation Disturbances 1Infertility 1Hirsutism 1Endometrial Neoplasms 1Depression 1Breast Neoplasms 1Bipolar Disorder 1Anxiety Disorders 1Advanced Malignancies 1

Interventions

Metformin 3drospirenone and ethinyl estradiol combination 2Caloric Restriction 2cinnulin PF 1Yoga 1Ultrasonography 1Sugars 1Robotic Surgical Procedures 1Population Groups 1Inositol 1Hysterectomy 1Hematologic Tests 1Glucose Tolerance Test 1Folic Acid 1Ethinyl Estradiol 1Doxycycline 1Diet 1Cyproterone acetate, ethinyl estradiol drug combination 1Control Groups 1Contraceptives, Oral 1Acupuncture Therapy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Menstruation Disturbances × Ethinyl Estradiol × Clear all
NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical Academy

Phase 4 Unknown
200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡